Article History
Received: 17 June 2021
Accepted: 16 July 2021
First Online: 19 August 2021
Competing interests
: P-CH received research grants from Elixron Immunotherapeutics and serves as scientific advisors for Acepodia, Elixiron Immunotherapeutics, and Novartis.